ARTYKUŁ PRZEGLĄDOWY
Rzadkie przyczyny owrzodzeń twarzy na przykładzie ziarniniaka Wegenera i piodermii zgorzelinowej
Karolina Kędzierska 1 , Krzysztof Sindrewicz 2 , Tomasz Smektała 2 , Magda Wiśniewska 1 , Marek Masiuk 3 , Ewelina Staniszewska 2 , Katarzyna Sporniak- Tutak 2 , Edyta Gołembiewska 1 , Kazimierz Ciechanowski 11. Department of Nephrology, Transplantology and Internal Medicine, Pomeranian Medical University, Szczecin, Poland
2. Department of Maxillofacial Surgery, Pomeranian Medical University, Szczecin, Poland
3. Department of Pathomorphology, Pomeranian Medical University, Pomeranian Medical University, Szczecin, Poland
Opublikowany: 2016-03-16
DOI: 10.5604/17322693.1197372
GICID: 01.3001.0009.6801
Dostępne wersje językowe: pl en
Wydanie: Postepy Hig Med Dosw 2016; 70 : 210-218
Abstrakt
Przypisy
- 1. Boudny C., Nievergelt H., Braathen L.R., Simon D.: Wegener’sgranulomatosis presenting as pyoderma gangrenosum. J. Dtsch.Dermatol. Ges., 2008; 6: 477-479
Google Scholar - 2. Callen J.P.: Pyoderma gangrenosum. Lancet, 1998; 351: 581-585
Google Scholar - 3. Castillo R.F., Cañadas-De la Fuente G.A., Husein-Elahmed H., Cantero-Hinojosa J.: Pyoderma gangrenosum developing over an arteriovenousfistula scar. Intern. Med. J., 2011; 41: 436-437
Google Scholar - 4. Daoud M.S., Gibson L.E., DeRemee R.A., Specks U., el-Azhary R.A.,Su W.P.: Cutaneous Wegener’s granulomatosis: clinical, histopathologic,and immunopathologic features of thirty patients. J. Am. Acad.Dermatol., 1994; 31: 605-612
Google Scholar - 5. Francès C., Du L.T., Piette J.C., Saada V., Boisnic S., Wechsler B.,Blétry O., Godeau P.: Wegener’s granulomatosis. Dermatologicalmanifestations in 75cases with clinicopathologic correlation. Arch.Dermatol., 1994; 130: 861-867
Google Scholar - 6. Hoffman M.D.: Pyoderma gangrenosum associated with c-ANCA(h-lamp-2). Int. J. Dermatol., 2001; 40: 135-137
Google Scholar - 7. Iwatani H., Uzu T., Kakihara M., Nakayama Y., Kanasaki K., YamatoM., Hirai Y., Umimoto K., Yamauchi A.: A case of Wegener’s granulomatosiswith pulmonary bleeding successfully treated with doublefiltration plasmapheresis (DFPP). Clin. Exp. Nephrol., 2004; 8: 369-374
Google Scholar - 8. Jackson J.M., Callen J.P.: Pyoderma Gangrenosum. Emedicine.http://emedicine.medscape.com/article/1123821-overview(28.01.2016)
Google Scholar - 9. Jacob S.E., Martin L.K., Kerdel F.A.: Cutaneous Wegener’s granulomatosis(malignant pyoderma) in a patient with Crohn’s disease.Int. J. Dermatol., 2003; 42: 896-898
Google Scholar - 10. Jayne D.R., Gaskin G., Rasmussen N., Abramowicz D., FerrarioF.,Guillevin L., Mirapeix E., Savage C.O., Sinico R.A., Stegeman C.A.,Westman K.W., van der Woude F.J., de Lind van Wijngaarden R.A.,Pusey C.D.: European Vasculitis Study Group: Randomized trial ofplasma exchange or high-dosage methylprednisolone as adjunctivetherapy for severe renal vasculitis. J. Am. Soc. Nephrol., 2007;18: 2180-2188
Google Scholar - 11. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., GrossW.L., Hagen E.C., Hoffman G.S., Hunder G.G., Kallenberg C.G., et al.:Nomenclature of systemic vasculitides. Proposal of an internationalconsensus conference. Arthritis Rheum., 1994; 37: 187-192
Google Scholar - 12. Jiménez-Gallo D., Albarrán-Planelles C., Linares-Barrios M.,Rodríguez-Hernández C., Martínez-Rodríguez A., García-MorenoE., Bravo-Monge R.: Pyoderma gangrenosum and Wegener granulomatosis-like syndrome induced by cocaine. Clin. Exp. Dermatol.,2013; 38: 878-882
Google Scholar - 13. Kawakami T., Obara W., Soma Y., Mizoguchi M.: Palisading neutrophilicgranulomatous dermatitis in a Japanese patient with Wegener’sgranulomatosis. J. Dermatol., 2005; 32: 487-492
Google Scholar - 14. Kouba D.J., Mimouni D., Ha C.T., Nousari C.H.: Limited Wegener’sgranulomatosis manifesting as malignant pyoderma with cornealmelt. Int. J. Dermatol., 2003; 42: 902-904
Google Scholar - 15. Kuchel J., Lee S.: Cutaneous Wegener’s granulomatosis: a variantor atypical localized form? Australas. J. Dermatol., 2003; 44: 129-135
Google Scholar - 16. Leavitt R.Y., Fauci A.S., Bloch D.A., Michel B.A., Hunder G.G., ArendW.P., Calabrese L.H., Fries J.F., Lie J.T., Lightfoot R.W. Jr., et al.: TheAmerican College of Rheumatology 1990 criteria for the classificationof Wegener’s granulomatosis. Arthritis Rheum., 1990; 33: 1101-1107
Google Scholar - 17. Le Hello C., Bonte I., Mora J.J., Verneuil L., Noël L.H., Guillevin L.: Pyodermagangrenosum associated with Wegener’s granulomatosis: partialresponse to mycophenolate mofetil. Rheumatology, 2002; 41: 236-237
Google Scholar - 18. Mills B.J.: Wound healing: the evidence for hyperbaric oxygentherapy. Br. J. Nurs., 2012; 21 (Suppl. 20): S28-S34
Google Scholar - 19. Nölle B., Specks U., Lüdemann J., Rohrbach M.S., DeRemee R.A.,Gross W.L.: Anticytoplasmic autoantibodies: their immunodiagnosticvalue in Wegener granulomatosis. Ann. Intern. Med., 1989; 111: 28-40
Google Scholar - 20. Perkins G.D., Moudgil H., Jones R.: Pyoderma gangrenosum.Thorax, 2000; 55: 347
Google Scholar - 21. Powell F.C., Winkelmann R.K.: Malignant pyoderma. Br. J. Dermatol.,1983; 109: 597-603
Google Scholar - 22. Reichrath J., Bens G., Bonowitz A., Tilgen W.: Treatment recommendationsfor pyoderma gangrenosum: an evidence-based reviewof the literature based on more than 350 patients. J. Am. Acad. Dermatol.,2005; 53: 273-283
Google Scholar - 23. Schönermarck U., Lamprecht P., Csernok E., Gross W.L.: Prevalenceand spectrum of rheumatic diseases associated with proteinase3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology, 2001; 40: 178-184
Google Scholar - 24. Sinovich V., Snow J.: Protracted superficial Wegener’s granulomatosis.Australas. J. Dermatol., 2003; 44: 207-214
Google Scholar - 25. Szõcs H.I., Torma K., Petrovicz E., Hársing J., Fekete G., KárpátiS., Horváth A.: Wegener’s granulomatosis presenting as pyodermagangrenosum. Int. J. Dermatol., 2003; 42: 898-902
Google Scholar - 26. Szpirt W.M., Heaf J.G., Petersen J.: Plasma exchange for inductionand cyclosporine A for maintenance of remission in Wegener’sgranulomatosis – a clinical randomized controlled trial. Nephrol.Dial. Transplant., 2011; 26: 206-213
Google Scholar - 27. Szymańska B., Kawecki M., Knefel G.: Kliniczne aspekty hiperbariitlenowej. Wiad. Lek., 2006; 59: 105-109
Google Scholar - 28. Wollina U.: Clinical management of pyoderma gangrenosum.Am. J. Clin. Dermatol., 2002; 3: 149-158
Google Scholar - 29. Wong Y.W., Lyon C.C., Benbow E.W., Bradley B.L., Beck M.H.:Pyoderma gangrenosum in a thoracotomy wound associated with apulmonary cavitating lesion. Clin. Exp. Dermatol., 2003; 28: 274-276
Google Scholar - 30. Zycinska K., Wardyn K., Zielonka T.M., Nitsch-Osuch A., SmolarczykR.: Cutaneous changes: an initial manifestation of pulmonaryWegener’s granulomatosis. Adv. Exp. Med. Biol., 2013; 755: 307-310
Google Scholar